Compile Data Set for Download or QSAR
Report error Found 56 Enz. Inhib. hit(s) with all data for entry = 10487
LigandPNGBDBM426342(US10526325, Compound A18 | US10829489, Compound A1...)
Affinity DataIC50: 300nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426358(US10526325, Compound A34 | US10829489, Compound A3...)
Affinity DataIC50: 300nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426356(US10526325, Compound A32 | US10829489, Compound A3...)
Affinity DataIC50: 300nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426376(US10526325, Compound A52 | US10829489, Compound A5...)
Affinity DataIC50: 300nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426354(US10526325, Compound A30 | US10829489, Compound A3...)
Affinity DataIC50: 300nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426362(US10526325, Compound A38 | US10829489, Compound A3...)
Affinity DataIC50: 300nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426364(US10526325, Compound A40 | US10829489, Compound A4...)
Affinity DataIC50: 300nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426348(US10526325, Compound A24 | US10829489, Compound A2...)
Affinity DataIC50: 300nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426378(US10526325, Compound A54 | US10829489, Compound A5...)
Affinity DataIC50: 300nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426346(US10526325, Compound A22 | US10829489, Compound A2...)
Affinity DataIC50: 300nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426344(US10526325, Compound A20 | US10829489, Compound A2...)
Affinity DataIC50: 300nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM472700((R)-3,3,3-Trifluoro-2-hydroxy-2-methyl-1-(7-methyl...)
Affinity DataIC50: 300nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426338(US10526325, Compound A14 | US10829489, Compound A1...)
Affinity DataIC50: 300nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426324(US10526325, Compound A1 | US10829489, Compound A1 ...)
Affinity DataIC50: 300nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM472696((2R)-3,3,3-trifluoro-1-[1-(4-fluorophenyl)-7-methy...)
Affinity DataIC50: 300nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426326(US10526325, Compound A3 | US10829489, Compound A3 ...)
Affinity DataIC50: 300nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426327(US10526325, Compound A4 | US10829489, Compound A4 ...)
Affinity DataIC50: 300nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426328(US10526325, Compound A5 | US10829489, Compound A5 ...)
Affinity DataIC50: 300nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426333(US10526325, Compound A10 | US10829489, Compound A1...)
Affinity DataIC50: 300nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426332(US10526325, Compound A9 | (2R)-1-[1-(4-chloropheny...)
Affinity DataIC50: 300nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426330(US10526325, Compound A7 | US10829489, Compound A7 ...)
Affinity DataIC50: 300nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426371(US10526325, Compound A47 | US10829489, Compound A4...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426359(US10526325, Compound A35 | US10829489, Compound A3...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426360(US10526325, Compound A36 | US10829489, Compound A3...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426361(US10526325, Compound A37 | US10829489, Compound A3...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426372(US10526325, Compound A48 | US10829489, Compound A4...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426363(US10526325, Compound A39 | US10829489, Compound A3...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426324(US10526325, Compound A1 | US10829489, Compound A1 ...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426374(US10526325, Compound A50 | US10829489, Compound A5...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426370(US10526325, Compound A46 | US10829489, Compound A4...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426366(US10526325, Compound A42 | US10829489, Compound A4...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426373(US10526325, Compound A49 | US10829489, Compound A4...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426326(US10526325, Compound A3 | US10829489, Compound A3 ...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426327(US10526325, Compound A4 | US10829489, Compound A4 ...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426375(US10526325, Compound A51 | US10829489, Compound A5...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426353(US10526325, Compound A29 | US10829489, Compound A2...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426352(US10526325, Compound A28 | US10829489, Compound A2...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426351(US10526325, Compound A27 | US10829489, Compound A2...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426349(US10526325, Compound A25 | US10829489, Compound A2...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426345(US10526325, Compound A21 | US10829489, Compound A2...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426343(US10526325, Compound A19 | US10829489, Compound A1...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM472701((R)-3,3,3-Trifluoro-2-hydroxy-2-methyl-1-(7-methyl...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426339(US10526325, Compound A15 | US10829489, Compound A1...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM472697((2R)-3,3,3-trifluoro-1-[2-(4-fluorophenyl)-7-methy...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426379(US10526325, Compound A55 | US10829489, Compound A5...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426331(US10526325, Compound A8 | US10829489, Compound A8 ...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426329(US10526325, Compound A6 | US10829489, Compound A6 ...)
Affinity DataIC50: 1.65E+3nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426377(US10526325, Compound A53 | US10829489, Compound A5...)
Affinity DataIC50: 2.65E+4nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426380(US10526325, Compound A56 | US10829489, Compound A5...)
Affinity DataIC50: 2.65E+4nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM426365(US10526325, Compound A41 | US10829489, Compound A4...)
Affinity DataIC50: 2.65E+4nMAssay Description:The biochemical activity assay for PDHK2 is based on the inactivation of PDC through phosphorylation by PDHK2. The assay is run in two steps: the enz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2022
Entry Details
Go to US Patent

Displayed 1 to 50 (of 56 total ) | Next | Last >>
Jump to: